BURLINGTON, Mass.--(BUSINESS WIRE)--Edgewise Networks, the industry’s first microsegmentation platform based on software identity, announced today it has received approval from the U.S. Patent and ...
– EDG-5506, a drug candidate designed to arrest muscle fiber breakdown in BMD and Duchenne muscular dystrophy (DMD), continues to advance in Phase 1 – “The FDA’s decision to grant EDG-5506 Fast Track ...
The last time I spoke about Edgewise Therapeutics (EWTX) it was with a Seeking Alpha article entitled "Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst." With respect to ...
Hello, and welcome to the Edgewise Therapeutics Update Call. [Operator Instructions] As a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time.
Edgewise Networks has emerged from stealth mode with an approach to network security that is says fixes the biggest problem in firewalls: their reliance on IP addresses, the basic identifier for ...
In addition to being too complex, Smith says traditional methods of microsegmention take months or years to implement, and those that rely on IP address-based controls require constant updates as ...
Edgewise Networks will significantly improve the security of east-west communication by verifying the identity of application software, services and processes, Zscaler said. Zscaler has purchased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results